Can-Fite BioPharma Ltd. (CANF) Free cash flow 2017–2025
Can-Fite BioPharma Ltd. (CANF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.0MFY2025 · since FY2017: -$9.0M → -$9.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.0M | -17.1% |
| FY2024 | -$7.6M | +9.5% |
| FY2023 | -$8.4M | +21.9% |
| FY2022 | -$10.8M | -9.5% |
| FY2021 | -$9.9M | +18.4% |
| FY2020 | -$12.1M | -9.0% |
| FY2019 | -$11.1M | -164.7% |
| FY2018 | -$4.2M | +53.4% |
| FY2017 | -$9.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice